|
CREB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.003700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88250999999529E-05 |
| Normal-vs-Stage2 |
1.117640E-01 |
| Normal-vs-Stage3 |
4.759800E-01 |
| Normal-vs-Stage4 |
4.477200E-01 |
| Stage1-vs-Stage2 |
3.640800E-01 |
| Stage1-vs-Stage3 |
1.203550E-01 |
| Stage1-vs-Stage4 |
3.033200E-01 |
| Stage2-vs-Stage3 |
5.478800E-01 |
| Stage2-vs-Stage4 |
7.882800E-01 |
| Stage3-vs-Stage4 |
8.267000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.619200E-04 |
| Normal-vs-AfricanAmerican |
1.762960E-04 |
| Normal-vs-Asian |
3.143900E-02 |
| Caucasian-vs-AfricanAmerican |
4.571400E-01 |
| Caucasian-vs-Asian |
8.443800E-01 |
| AfricanAmerican-vs-Asian |
9.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05329999999793E-06 |
| Normal-vs-Female |
8.420600E-01 |
| Male-vs-Female |
3.437200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.882480E-03 |
| Normal-vs-Extreme_Weight |
5.87770000004539E-07 |
| Normal-vs-Obese |
8.480200E-02 |
| Normal-vs-Extreme_Obese |
3.770500E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.129400E-01 |
| Normal_Weight-vs-Obese |
2.173400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.296000E-01 |
| Extreme_Weight-vs-Obese |
1.448130E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.872400E-01 |
| Obese-vs-Extreme_Obese |
1.648980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.079200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.521700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.57239999998282E-06 |
| Normal-vs-Age(81-100Yrs) |
1.59593999999874E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.677400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.795900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.866230E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207620E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.496800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.415600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86559999999503E-05 |
| Normal-VS-Type2 PRCC |
1.85773999999972E-05 |
| Normal-VS-KIRP CIMP |
1.052830E-01 |
| Normal-VS-Unclassified PRCC |
6.135600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.581000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.643540E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.032000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.303630E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.067500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.958000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75179999994945E-06 |
| Normal-vs-N1 |
5.365800E-01 |
| Normal-vs-N2 |
2.413200E-01 |
| N0-vs-N1 |
6.038200E-03 |
| N0-vs-N2 |
3.531000E-01 |
| N1-vs-N2 |
4.455600E-01 |
|
|
